5.00936
Vitamin D3 (cholecalciferol) cryst. (1 g = 40 Mio.I.U.)
EMPROVE® ESSENTIAL, Ph. Eur., BP, USP
Synonym(s):
Vitamin D₃ (cholecalciferol) cryst. (1 g = 40 Mio.I.U.), Colecalciferol, Cholecalciferol
Select a Size
About This Item
Quality Segment
agency
BP, Ph. Eur., USP
product line
EMPROVE® ESSENTIAL
form
solid
mp
82-87 °C
solubility
<0.1 g/L
application(s)
liquid formulation
pharmaceutical
storage temp.
2-8°C
SMILES string
O[C@H]1CCC(=C)\C(=C\C=C2\[C@H]3[C@@]([C@H](CC3)[C@@H](CCCC(C)C)C)(CCC\2)C)\C1
InChI
1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13+/t21-,24+,25-,26+,27-/m1/s1
InChI key
QYSXJUFSXHHAJI-FVUVGDFOSA-N
General description
Application
Legal Information
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - STOT RE 1 Oral
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
Substances Subject to be Indicated Names
ishl_indicated
Substances Subject to be Notified Names
ishl_notified
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Related Content
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 5.00936.0100 | 04022536257327 |
| 5.00936.0010 | 04022536257310 |